GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human FTO in complex with small-molecule inhibitors

Analyse Crystal structure of human FTO in complex with small-molecule inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6AEJ
Type
protein
Length
421 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.8
Source
Homo sapiens
Molecule
Alpha-ketoglutarate-dependent dioxygenase FTO,Alpha-ketoglutarate-dependent dioxygenase…
EC
1.14.11.-
UniProt
Q9C0B1
Ligands
7YC, ZN
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · resolution 2.8 · 1 distinct chain · 37% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-ketoglutarate-dependent dioxygenase FTO,Alpha-ketoglutarate-dependent dioxygenase FTO (EC 1.14.11.-)protein42137% helix, 22% strandQ9C0B1

Ligands and binding sites

  • 7YC · (E)-3-[3-nitro-4,5-bis(oxidanyl)phenyl]-2-(1,3-oxazinan-3-ylcarbonyl)prop-2-enenitrile · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13270.690.83447YC, ZN
2720.350.7616empty

Compared structures

  • 6AEJ · Crystal structure of human fto in complex with small-molecule inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9C0B1 · AlphaFold monomer V2.0 prediction for alpha-ketoglutarate-dependent dioxygenase fto… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.